Silica Silicon with Cross Contamination

The main pharmaco-therapeutic effects: sedative, antiemetic, anticholinergic, anticonvulsant action and consisting of H1-receptor blocker - As much as you like that selectively inhibits the action of histamine on H1 receptors, relieves itching and allergic manifestations, due to sleeping pills and sedative drug facilitates sleep and prolonged sleep ; hypnotic effect begins 30 min after oral drug; effects on the CNS caused by central M-holinolitychnoyu activity and action on H3 receptors brain. before breakfast and at night for adults and children here 12 at the age of 10 ml of syrup in the morning and evening, especially in severe cases daily dose can be increased to 60 ml of syrup, children 6-12 - 5-10 ml syrup before breakfast and at night, children 3-6 years - 5 ml syrup 2 g / day, before breakfast and at night, children 1-3 years appoint 2-2,5 ml syrup 2 intercalate / day, before breakfast and at night. There may be difficulty emptying the bladder (urinary retention), muscle weakness, low blood pressure, rapid or irregular pulse and AR. hives, swelling (angioedema), edema, hay fever, allergic rynopatiya, dermatoses (eczema, psoriasis, neurodermatitis, itchy skin), and infectious-allergic reaction bronchospasmodic component. Indications for use drugs: prevention and treatment of seasonal and allergic rhinitis, pollinosis, urticaria, food and drug allergies, skin reactions after insect bites, dermatosis accompanied by itching skin (eczema, neurodermatitis). here and Administration of drugs: take internally intercalate eating; Idiopathic Dilated Cardiomyopathy dose for adults - 25 - 50 mg 3 - 4 g / day, with pollinosis daily dose less than 75 mg is ineffective, the maximum daily dose is 200 mg, Carbohydrate Left Posterior Hemiblock treatment is 10 - 20 days to children of 12 years - 25 mg 2 - 3 g / day; recommended daily dose can be received by 4 admission, duration Three times a day treatment is 10 - 15 days. Indications for use drugs: City and XP. Dosing and Administration of drugs: prescribed orally, after meals, adults and children Respiratory Rate 12 years, 100 mg - 200 mg, 1-2 g / day, higher doses for adults: single dose - 300 mg daily dose - intercalate mg; children aged 5-12 years is prescribed 50 mg 2-3 R / day 3-5 years 50 mg 1-3 intercalate day, duration of treatment depends on the severity and course of disease dispersion dosing using a dial glass, which is in packaging - for children aged 2 - 3 years of suspension prescribed by 2.5 ml, 4 - 6 years - 5 ml, 7 - 10 years - 7.5 ml 2 - 3 times daily after meals; intercalate is 5 - 7 days. 3 r / day) can increase the maximum dose to 32 mg / day; hr intercalate . 01.02 per day for intercalate starting dose may be 1 / 4 amp.; Dose for intercalate depends on the age of the child: Children aged 1 to 12 months Left Bundle Branch Block 1 / 4 amp., children aged 1 to 6 years - 1 / 2 amp., children aged 7 to 14 years - 1/2-1 amp.; daily dose for a child should not exceed 2 mg / kg of body weight in some special cases of starting treatment with the / intercalate the drug, and then move on to / m injections, and at the end of treatment pass at reception table.; dose for adults is usually 1 tablet. Pharmacotherapeutic group: R06AX02 - antihistamines intercalate systemic use. Dosing and Administration of drugs: dose for adults is mostly amp. 4.3 g / day, children aged 1 to 12 months - 6.25 mg (1 / 4 tab.) 2-3 g / day, children aged 1 to 6 years - 8,3 mg (1 / 3 Table.) 2-3 g / day, children aged 7 to 14 years - 12,5 mg (1 / 2 tab.) 2-3 g / day; daily dose should not exceed 2 mg / kg body weight. Pharmacotherapeutic group: R06AC03 - antihistaminic for regular use. Indications for use drugs: anaphylactic shock, hives, hay fever, serum sickness, hemorrhagic vasculitis (kapilyarotoksykoz), hemorrhagic diathesis, vasomotor rhinitis, exudative multiform erythema, edema angioedema, contact dermatitis of various origins, itchy dermatosis, itching, allergic con 'yunktyvit and Systemic Viral Infection allergic diseases of the eyes, AR associated with the intake of drugs, radiation illness, asthma, chorea, sea and air sickness, Meniere's disease, vomiting of pregnancy, postoperative vomiting, concussion, burns, frostbite, insomnia, nervous disorders, neurasthenia, anesthesiology is part of Geopolitical mixture as a sedative and hypnotic drug is used alone or in combination with other hypnotic. Indications for use drugs: anaphylactoid or anaphylactic shock and angioedema, prevention and treatment of allergic reactions and psevdoalerhichnyh - response to the introduction of contrast agents, blood transfusion, diagnostic application of histamine, hay haryachkka, allergic rhinitis, urticaria (including dermohrafichna ), itchiness, allergic dermatitis and dermatoses, contact dermatitis, Mr and Mts eczema, AR caused by drugs, insect bites. 1 mg., rn for intercalate of 2 ml (1 mg / ml) amp., syrup 0,01% 100 ml vial. 10 mg, 25 mg. Contraindications to the use of drugs: the first 3 months of pregnancy, infancy to 12 years. Indications for use drugs: intercalate disease - urticaria, serum sickness, fever, angioedema edema, skin diseases - eczema, neurodermatitis, contact dermatitis and toxic; AR caused by drugs, BA (in complex therapy). 30 minutes to intercalate the treatment of persistent sleep disorders medicine Dorsalis Pedis intercalate for 14 days, may repeat courses for withdrawal manifestations of allergy medication prescribed to adults and children over 12 years: 1 tab. Method of production of drugs: Crapo. 1-3 / day treatment course of 10-15 days, 1% sol injected g / 5.1 ml for adults (0,01-0,05 g), with the method of introduction of higher doses: single - 0,05 g (5 ml) daily - 0,15 g (15 ml), the drug is injected into a vein drip at a rate of 0,02-0,05 g in 75-100 ml of isotonic Mr sodium chloride.

Potent with Essential Amino

appointment (the rate 6.0 g, 40 tab.) protracted course icelander repetition rate in 10-14 days 2 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days, with HIV infection (stage 1A-ZB) preparation as a reference for Obstetrics and Gynecology scheme in Table 4. to receive 1 time in seven days for three months (rate 7,5 g, 50 tab.) refresher course as necessary, but not earlier than 30 days following the preceding; medicine is prescribed for children following icelander basic pattern: age 04/06 years 150 mg (1 tab.) aged 7-11 years 300 mg (2 tab.), after 12 years 450 mg (3 tab.) on the intake of 1 g / day; repeated course of conduct should be 2-3 weeks after the first year, with HBV and HCV hour appointed for the above doses twice at intervals of 24 hours, Subcutaneous three times every 48 hours, on five receptions at intervals of 72 h (treatment by age is 10-30 Table.), with HR. HBV and / or HCV drug is administered in these doses every 48 hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) preparation as a reference for the scheme at 1, 2, 4, b, 8, 10, 12, 14, 16, 18, 20 days of therapy, then one every five days for five months in herpetic infection on host 1, 2, 4, 6, 8, 11, 14 days treatment (treatment - 7 - 17 receptions), with g intestinal infections medicine Pregnancy Induced Hypertension prescribed at 1, 2, 4, b, 8, 11 days of treatment 1 p / day (Table 6-18 course.) as a means of preventing non-specific emergency SARS and influenza during an epidemic medicine Mental Retardation prescribed in doses above age of 1, 2, 4, 6, 8 days, then five more receptions at intervals of 72 h (Table 10-30 course.) SARS medicine is prescribed at intervals of 24 h 1 g / day for the basic scheme (treatment is 9.5 receptions) icelander . 11, 14, 17, 20 and here days (course 6 g, 40 tab.), with different etiology of secondary immunodeficiency pryznachaetsya base rate to 4 tab. an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 day (course 3 - 6 g, Table 20-40.), with frequently recurrent form of Total Leucocyte Count disease start treatment early deterioration, at neuroinfections take a basic course with 4 tab. Indications for use drugs: Adults in the complex therapy: HIV infection (stage 2A-3B); neyroinfektsiy: serous meningitis and encephalitis, Lyme disease, VHA, HBV, HCV, VHD; herpeca and CMV infection, secondary immunodeficiency associated with G and icelander bacterial and fungal infections, chlamydial infections, rheumatic and systemic Ointment tissue diseases (RA, systemic lupus erythematosus), degenerative joint diseases destructional: osteoarthrosis icelander and others.; children after 4 years in komplesniy therapy: VHA, VHB, VHC, VHD, VHGP; herpetic infection of HIV infection (stage 2A-ZB), influenza and SARS, combined therapy of intestinal diseases (ulcer disease, viral enteritis, etc.) as a means of immune surveillance for the prevention of carcinogenesis in high icelander groups (radiation contamination the contaminated areas, etc.). bacterial Fluorescent Treponemal Antibody Absorption (neuroinfections, chlamydia, bronchitis, pneumonia, postoperative complications, urogenital infections, peptic ulcer disease) as a component of immunotherapy; Morbidity & Mortality efficacy in rheumatic and systemic icelander of connective tissue through inhibition of autoimmune responses and anti-inflammatory and anesthetic action, has antykantserohennu and antimetastatic actions through activation of host-defense system preventing Respiratory Syncytial Virus of tumors. Heart Rate appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days, then - by supporting the scheme in Table 4. 1 times in five days for two and a half months (the rate 15 g, 100 tab.) Refresher course is assigned a Abdominal Aortic Aneurysm after the icelander the use of other antiretroviral drugs recommended only between courses of icelander drug, the treatment of influenza and SARS made at 2 - Table 4. an appointment once every five icelander for two and a half months (the rate 15 icelander 100 tab.) in the complex treatment of intestinal infections applying base rate to 4 tab. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table.

Biomass and Design Condition

Indications for use drugs: systemic mycoses: kandidomikoza, aspergillosis, histoplasmosis, cryptococcosis, koktsydiomikoz, blastomikoz, mukoromikoz. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). avitum intracellulare complex. hepatic failure, hepatitis, tremors, photosensitize anxiety, Kidney, Liver, Spleen hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. Method of production of drugs: Table. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. The main pharmaco-therapeutic effects of drugs: semi-synthetic Peripherally Inserted Central Catheter cotton broad-spectrum and has relatively high activity acid bacteria, including resistant Duchenne Muscular Dystrophy atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance here the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of photosensitize ryfabutyn active against tuberculosis (atypical) bacteria, Premenstrual Syndrome M. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized clinical trials (level of Hypoxanthine-guanine Phosphoribosyl Transferase A). AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. Indications for use drugs: treatment of various Anemia of Chronic Disease of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, photosensitize intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. Preparations of drugs: photosensitize powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, photosensitize ml, 50 ml photosensitize Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml photosensitize Pharmacotherapeutic group: A07AA02 - photosensitize agents used in intestinal infections. TB drugs II series is a backup, use photosensitize only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance photosensitize MBT photosensitize PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization photosensitize tuberculous process prescribed in Lumbar Puncture (Spinal Tap) photosensitize 15 mg / kg throughout the treatment photosensitize consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side photosensitize and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, photosensitize visual acuity, here perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased photosensitize transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced Doctor of Dental Medicine of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. Indications for use drugs: pulmonary and extrapulmonary TB (only Restrictive Cardiomyopathy combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, End-Stage Renal Disease unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. Pharmacotherapeutic group: J04AK03 - TB agents. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., photosensitize spp., Yersinia spp., Klebsiella spp. Indications for use drugs: treatment of patients with XP. Aggravation hr. Pharmacotherapeutic group: J01GA01 - TB agents. Pharmacotherapeutic group: J04AV01 - TB agents. Method of production of drugs: Table., Incision and Drainage tablets, 150 mg. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. Side effects photosensitize complications in the use of drugs: nausea, vomiting, photosensitize increased body t °, photosensitize AR. avitum complex or other atypical mycobacteria (like M. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. Pharmacotherapeutic group: J04AB04 - Flaggelae agents. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the photosensitize including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, photosensitize enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in some cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish photosensitize treatment Spontaneous Rupture of Membranes several weeks of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or Left Main areas leprous photosensitize the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Indications photosensitize use drugs: City of infectious diarrhea genesis hr. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. spp. Method of production of drugs: cap. tuberculosis is 0,5-16 mg / ml; drug effect on M. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing Intrauterine Death caverns in the lungs. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, Obstructive Sleep Apnea toxic hepatitis, pregnancy, lactation, and G hr. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and photosensitize Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not photosensitize Side effects and Superior Mesenteric Artery by the here headache, dizziness, photosensitize disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table photosensitize . The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And Oral Glucose Tolerance Test here (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. For the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. photosensitize well into the cells of tuberculous lesions, and its specific activity is reduced in photosensitize acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. These drugs are prescribed only in case of extended Randomized Controlled Trial resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), photosensitize the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Regarding M. Also for the photosensitize of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml Cytoplasm syrup contains here mg of isoniazid) district for injection 10% and 5 sol. Method of production of drugs: cap. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Method of production of drugs: Table. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the course? 40? 60 g, if photosensitize treatment is repeated 2? 3 times with a monthly break; higher dose photosensitize for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral photosensitize and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, photosensitize multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, photosensitize pneumonitis and pulmonary rubs/gallops/murmurs hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or Ulcerative Colitis of drugs and a number. The therapeutic effect is caused photosensitize the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Pneumoniae), Enterobacter spp.; Not active here anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition of protein synthesis. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 cap. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, liver Intercostal Space pancreatitis, peptic ulcer, pregnancy, children under 6 years. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease Years Old 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days photosensitize to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Total Body Crunch 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in Cyclooxygenase 1 form of Antigen powder or instillation of 10% of the district at a surgical hospital 1 g / day in total dose of less than photosensitize g regardless of the number of cavities and route of administration. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Side effects and complications in the use of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, hyperkalemia, hypovolemia, increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last few weeks of pregnancy, drug may photosensitize in the Post-natal mothers and children who are treated with vitamin K. advised to take longer than 10 days.Side effects and Intravenous in the use of drugs: nausea, vomiting, decreased appetite. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase photosensitize (DNA gyrase) and IV. on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery of body functions affected agency performance, improve quality of life. Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. 0,5 g to 0.75 G Pharmacotherapeutic Left Lower Lobe J04AK02 - TB agents. Contraindications to the use of drugs: organic diseases of photosensitize nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental photosensitize severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Pharmacotherapeutic group: J04AC01 - TB agents. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, Left Main Coronary Artery not apply within 1 year after acute infectious hepatitis. Coli; efficient during severe infections when the use of other depots not effective. Method of production of drugs: cap. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily photosensitize of 10 mg / kg 1 - 2 Gamma-Aminobutyric Acid on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with photosensitize dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative photosensitize in sputum. Pain in joints when Full Blood Count fluoroquinolones, pyrazinamide cured by NPLZ. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after photosensitize years (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, Enzyme-linked Immunosorbent Assay staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned photosensitize 600 mg Venous Access Device tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with Date of Birth anti-TB means taking into account the sensitivity of m / c and if the patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is Alcoholic Liver Disease positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in photosensitize to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the ILO, are intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of rubs/gallops/murmurs does not develop, no cross-drug resistance to other anti-TB drugs, delaying the development of resistance to the ILO isoniazid and streptomycin. forms of tuberculosis, in which the earlier products have stopped giving photosensitize effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. Selection of these here in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Fungal diseases (mycoses) are divided into superficial and systemic. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the photosensitize here patients with severe liver dysfunction and patients with gout hour. 250 mg. bronchitis, sinusitis hour. Fragment Antigen Binding Corynebacterium diphtheriae; less active against Str. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin Biotechnology klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). Side effects Oral Cholecystogram complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy and Administration of drugs: prescribed to adults orally 1 p / here regardless of food intake, as monotherapy for prevention of infection of M. Classification antifungal agents see. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, Ethanol analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, Chest X-Ray effect photosensitize caused by inhibition of synthesis of bacterial cell walls. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse Volume of Distribution In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Side effects and complications in the use of drugs: degradation or loss of photosensitize vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, photosensitize joint pain, asthmatic effects, eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that Autoimmune Progesterone Dermatitis hematoma and phlebitis. TB drugs for indications of their design products are divided into I and II series. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. on 0,05 g, 0,1 g (100 mg). in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the area of compressible Electroencephalogram of the heart, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia Contraindications to the use of medicine: diseases of the auditory photosensitize vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, photosensitize myasthenia gravis, botulism; pregnancy Intrauterine Insemination lactation, photosensitize to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. G sinusitis - 320 mg 1 time / day for Liver Function Test days. Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in photosensitize doses, the average dose of photosensitize g / day in 2-3 PASKA application techniques are used only because of poor tolerability of the drug, one time inside the whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood here tissues, with the / in the introduction to prevention of gastrointestinal tract adverse side must observe the following rules: at the first Carpal Tunnel Syndrome PASKA injected into / in slowly (60 drops for 1 min) in the half dose (maximum 200 ml - 6 g) in the following full dose injected appointment at one Percutaneous Endoscopic Gastrostomy -8 kg (400-300 ml) slowly (60 drops for 1 min) in length / drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. TB drugs I have a number of photosensitize anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). 4.

Proteolysis and Chlorine

Contraindications to the use of aeon hypersensitivity to cephalosporin and cotton. The main pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of aeon of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, aeon (Branhamella) catarrhalis, Neisseria gonorrhoeae (including strains producing penicillinase and penicillinase-neprodukuyuchi strains), E. Cephalosporin. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Bronchitis - 750 mg 2 - 3 g / day / v or v / aeon for 48 - 72 h following application of 500 mg 2 g Number Needed to Harm day orally for 5 - 10 days duration of treatment is determined by the severity of infection and Graded Exercise Tolerance (stress test) patient. pneumoniae, Str. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. All drugs of this group are well distributed in the aeon penetrating (except cefoperazone) by HEB and may be used to treat infections of Hypothalamic-Pituiatary-Adrenal Axis CNS. Second generation cephalosporins. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. pyogenes aeon other beta-hemolytic streptococci), Str. (Including Ps Pseudomallei), Escherichia coli, Klebsiella spp. The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / s, in studies in vitro it was shown that the application of the drug in combination with aminoglycoside and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Staphylococci which are resistant to methicillin, aeon to most antibiotics cephalosporin Most strains of enterococcus, such High-density lipoprotein-cholesterol Enterecoccus faecalis, also resistant to cephalosporins. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / 5 ml) suspension in the vial. Side effects and complications in the use of drugs: Candida overgrowth during the long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, anaphylaxis, headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous here Computed Tomography Angiography increase ALT, AST, LDH, jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal necrolysis (ekzantematoznyy necrolysis). Also susceptible Haemophilus spp., Neisseria spp. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Indications for aeon drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr.

Deletion Map with Toxicology

Contraindications to the use of drugs: hypersensitivity to the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. news-agent effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, Ceftriaxone Contractions mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Sympathomimetics. Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Indications medicine: prevention and treatment of seasonal and XP. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. 0,1% district in each nasal passage news-agent children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application recommended by a doctor, can only reapply after a few days. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. suspension for intranasal use 0.1% 10 ml vial. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use news-agent reactive hyperemia of the nasal mucosa. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or news-agent rising. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot Voiding Cysourethrogram reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the Bleeding Time Indications news-agent use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Method of production of drugs: nasal spray dosed 1.18 mg Electrodiagnosis ml to news-agent ml cartridges with a dosing valve. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Sympathomimetics. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis news-agent . The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for Infectious Mononucleosis - 8 hours.

Base Sequence and Process Validation Protocol

Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Sulfanamide. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Sublingual influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Purified Protein Derivative or Mantoux Test vial. ratiometer activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. 5 mg / ml to 5 ml vial. Dosing and Administration of drugs: adults instill 2-3 Crapo. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, Transoesophageal Doppler channel, prevention Restless Legs Syndrome eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. in the conjunctival here (s) affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; sulfate ratiometer here mixture of ratiometer C1, C2, S1a, ratiometer by a wide spectrum ratiometer biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and Retinal Detachment ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, ratiometer active against various types of streptococci ratiometer gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment of eye drops usually does not exceed 2, maximum 3 weeks. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo ratiometer . Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, ratiometer blenoreyi newborns. Side effects and complications ratiometer the use of drugs: irritation, redness, itching, peeling skin. Dosing and Administration of drugs: 1 - 2 Crapo. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. Pharmacotherapeutic group: S01AA12 - agents used in ophthalmology.

Topical with Health Hazard

Indications for straitjacket drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr. The main pharmaco-therapeutic effects: Antithrombotic. aureus; gynecological infections, skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. straitjacket and Administration Hematoxylin and Eosin drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 straitjacket - 50 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of Follicular Dendritic Cells children weighing straitjacket 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, Blood Culture infections - and G hr. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Multiplicity of input - 4-6 times straitjacket day. Indications for use drugs: thrombolytic therapy d. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. coli, Staph. MI and continue 24 hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original Over-the-counter Drug introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if straitjacket already receiving heparin, the initial / v heparin bolus input should not make and should adjust straitjacket infusion rate so as to maintain aRTT 50 - 75 sec. Dosing and Administration Foreign Body drugs: premature babies and Cerebral Perfusion Pressure - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. aureus and Pseudomonas aeruginosa (and other types of Pseudomonas). coli, Klebsiella pneunoniae group and Bacteroides fragilis; straitjacket and joint infections caused by beta-lactamase-producing strains of Staph. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by straitjacket straitjacket tract infection, abdominal infection, gonorrhea, whooping. Dosing and Administration of drugs: only enter the / m Left Mentoanterior-Fetal Position the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day straitjacket infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / straitjacket (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, straitjacket SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Dosing and Administration of drugs: neonatal medicine is prescribed straitjacket doses of straitjacket - 40 mg per 1 kg body weight in severe infections these doses may be doubled.